Recent 8-K filings for DROR
Highest-materiality recent filing
Novint shell completes reverse merger with Dror Ortho-Design; raises $5.0M private placement
- Private Dror shareholders exchanged 235,088 shares for 7,576,999 Series A Preferred and 106,782,187 common shares.
- Concurrent private placement raised $5,025,000 gross proceeds; potential to increase to $6,000,000.
-
Dror Ortho-Design raises $275,000 via private placement of debentures due June 2026
Aggregate $275,000 principal, 0% interest, due June 28, 2026; holder can extend maturity in 60-day increments.
-
Dror Ortho-Design raises $200K via 0% debentures and warrants in private placement
Issued $200,000 principal of 0% debentures due April 27, 2026, convertible into common stock upon a future public offering.
-
Dror Ortho-Design raises $250K via private placement of 0% debentures due Feb 2026
Issued $250,000 aggregate principal of 0% interest debentures maturing February 28, 2026.
-
Dror Ortho-Design raises $200,000 via 0% debentures due Feb 2026, convertible upon public offering
Issued $200K aggregate principal amount of 0% debentures due Feb 2, 2026 to accredited investors in a private placement.
-
Entered Securities Purchase Agreement for $200,000 aggregate principal debentures, due September 17, 2025.
-
Dror Ortho-Design stockholders approve reverse stock split at ratio up to 1:2,000
Approved reverse stock split of common stock at ratio from 1:2 to 1:2,000; board sets exact ratio and timing.
-
Issued $200,000 principal of 0% interest debentures due August 15, 2025, with holder option to extend 60 days.
-
Dror Ortho-Design postpones special stockholder meeting to June 23, 2025
Special meeting moved from June 13 to June 23, 2025; time remains 10:00 a.m. Eastern.
-
Dror Ortho-Design raises $300K via private placement of 0% debentures due Aug 2025
Issued $300,000 aggregate principal of 0% interest debentures, maturing August 5, 2025, extendable by holder in 60-day increments.
-
Authorized common shares increased from 500M to 3,254,475,740 via Amended & Restated Charter filed Jan 4, 2024.
-
Quorum changed from majority to one-third of voting power present at stockholder meetings.
-
Dror Ortho-Design files certificate of correction to grant voting rights to Series A Preferred Stock
Filed certificate of correction to fix typographical error that omitted voting rights for Series A Convertible Preferred Stock.
-
Dror Ortho-Design dismisses auditor Sadler, Gibb; appoints Barzily And Co.
Dismissed Sadler, Gibb & Associates as independent auditor effective Oct 18, 2023.
-
Second closing on Sept 13, 2023: sold 181,818.17 preferred shares and 18,181,817 warrants.
-
Dror Ortho-Design amends 8-K to add director consulting agreement with Yehuda Englander
Corrective amendment adds Exhibit 10.14 – consulting agreement with director Yehuda Englander, dated June 1, 2022.
-
Novint shell completes reverse merger with Dror Ortho-Design; raises $5.0M private placement
Private Dror shareholders exchanged 235,088 shares for 7,576,999 Series A Preferred and 106,782,187 common shares.
-
Each Dror ordinary share exchanged for 1,048,585,364 shares of Novint Series A Convertible Preferred Stock.
Materiality & sentiment trend
Max materiality 1.00 · Median 0.40 · Most common event debt